Stephen M. Rosenthal, MD

Medical Director, Child and Adolescent Gender Center
Pediatric endocrinologist

Dr. Stephen M. Rosenthal is co-founder and medical director of the multidisciplinary UCSF Child and Adolescent Gender Center (CAGC), where he cares for young transgender patients. He also cares for pediatric patients with endocrine disorders, such as abnormalities involving thyroid function or growth and puberty. He previously served as program director for pediatric endocrinology and director of the pediatric endocrinology clinics.

Rosenthal has conducted numerous multicenter clinical trials (studies that evaluate promising new treatments using human subjects). He is one of four principal investigators for "The Impact of Early Medical Treatment in Transgender Youth," a multicenter study sponsored by the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. He has published many papers on the care of transgender youths in scholarly journals, such as Pediatrics and the Journal of Clinical Endocrinology & Metabolism. He was an appointed author of the World Professional Association for Transgender Health's updated standards of care. He also directs a collaboration between the CAGC and the San Francisco Department of Public Health to develop community outreach services for gender-diverse youths.

Rosenthal earned his medical degree from the Vagelos College of Physicians and Surgeons at Columbia University, where he also completed a residency in pediatrics. He completed a fellowship in pediatric endocrinology at UCSF.

An active member of the Pediatric Endocrine Society, Rosenthal has served as its president and on multiple committees. He also serves on the board of directors for the Endocrine Society. When that international organization created a task force to revise guidelines on care of transgender patients, he served as the Pediatric Endocrine Society's official representative and as a co-author.

Rosenthal feels fortunate to work in gender health and to be part of a dedicated care team. An avid figure skater outside of work, he has participated in adult competitions both nationally and internationally.

Clinics

Child and Adolescent Gender Center at San Mateo Primary & Specialty Care
1100 Park Place, Suite 100
San Mateo, CA 94403
Phone: (415) 502-8942
Fax: (650) 685-8392

Child and Adolescent Gender Center Clinic
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 353-7337
Fax (Attn: Dr. Stephen Rosenthal): (415) 476-8214

Disorders of Sex
Development Clinic

1825 Fourth St., Fifth Floor, 5B
San Francisco, CA 94158
Phone: (415) 353-2200
Fax: (415) 353-2480

Endocrinology Clinic
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 353-7337
Fax: (415) 476-8214

San Mateo Primary and Specialty Care Clinic
1100 Park Place, Suite 100
San Mateo, CA 94403
Appointments: (415) 502-8942

Conditions & Treatments

More about Stephen M. Rosenthal

Additional Languages

French

Education

Columbia University 1976

Residencies

Columbia University, Pediatrics 1979

Fellowships

UCSF, Endocrinology 1982

Selected Research and Publications

  1. Vance SR, Rosenthal SM. A Closer Look at the Psychosocial Realities of LGBTQ Youth. Pediatrics. 2018 Apr 16.
  2. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG. ENDOCRINE TREATMENT OF GENDER-DYSPHORIC/GENDER-INCONGRUENT PERSONS: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE. Endocr Pract. 2017 Dec; 23(12):1437.
  3. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 Nov 01; 102(11):3869-3903.
  4. Lopez X, Marinkovic M, Eimicke T, Rosenthal SM, Olshan JS. Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health. Curr Opin Pediatr. 2017 Aug; 29(4):475-480.
  5. Vance SR, Deutsch MB, Rosenthal SM, Buckelew SM. Enhancing Pediatric Trainees' and Students' Knowledge in Providing Care to Transgender Youth. J Adolesc Health. 2017 Apr; 60(4):425-430.
  6. Rosenthal SM. Transgender youth: current concepts. Ann Pediatr Endocrinol Metab. 2016 Dec; 21(4):185-192.
  7. Olson-Kennedy J, Cohen-Kettenis PT, Kreukels BP, Meyer-Bahlburg HF, Garofalo R, Meyer W, Rosenthal SM. Research priorities for gender nonconforming/transgender youth: gender identity development and biopsychosocial outcomes. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):172-9.
  8. Vance SR, Rosenthal SM. Treating Transgender Youth: Pushing the Dialogue Forward. J Adolesc Health. 2015 Oct; 57(4):357-8.
  9. Bonifacio HJ, Rosenthal SM. Gender Variance and Dysphoria in Children and Adolescents. Pediatr Clin North Am. 2015 Aug; 62(4):1001-16.
  10. Vance SR, Ehrensaft D, Rosenthal SM. Author's Response. Pediatrics. 2015 May; 135(5):e1366-7.
  11. Vance SR, Halpern-Felsher BL, Rosenthal SM. Health care providers' comfort with and barriers to care of transgender youth. J Adolesc Health. 2015 Feb; 56(2):251-3.
  12. Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Rosenthal SM, Shuster JJ, Zou B, Brusko TM, Hulme MA, Wasserfall CH, Mathews CE, Atkinson MA, Schatz DA. Anti-thymocyte globulin/G-CSF treatment preserves ß cell function in patients with established type 1 diabetes. J Clin Invest. 2015 Jan; 125(1):448-55.
  13. Rosenthal SM. Approach to the patient: transgender youth: endocrine considerations. J Clin Endocrinol Metab. 2014 Dec; 99(12):4379-89.
  14. Vance SR, Ehrensaft D, Rosenthal SM. Psychological and medical care of gender nonconforming youth. Pediatrics. 2014 Dec; 134(6):1184-92.
  15. Lazure P, Bartel RC, Biller BM, Molitch ME, Rosenthal SM, Ross JL, Bernsten BD, Hayes SM. Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology. BMC Health Serv Res. 2014 Jul 24; 14:319.
  16. Sherer I, Rosenthal SM, Ehrensaft D, Baum J. Child and Adolescent Gender Center: a multidisciplinary collaboration to improve the lives of gender nonconforming children and teens. Pediatr Rev. 2012 Jun; 33(6):273-5.
  17. Cheung CC, Cadnapaphornchai MA, Ranadive SA, Gitelman SE, Rosenthal SM. Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor. Int J Pediatr Endocrinol. 2012 Feb 10; 2012(1):3.
  18. Ranadive SA, Rosenthal SM. Pediatric disorders of water balance. Pediatr Clin North Am. 2011 Oct; 58(5):1271-80, xi-xii.
  19. Aslan IR, Baca EA, Charlton RW, Rosenthal SM. Respiratory syncytial virus infection as a precipitant of thyroid storm in a previously undiagnosed case of graves' disease in a prepubertal girl. Int J Pediatr Endocrinol. 2011; 2011:138903.
  20. Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, Kovoor A, Gitelman SE, Rosenthal SM, von Zastrow M, Bouvier M. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Mol Pharmacol. 2010 May; 77(5):836-45.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.